EE53 The Net Monetary Benefit of Introducing Sodium-Glucose Cotransporter-2 Inhibitors in Middle-Income Countries
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.306
https://www.valueinhealthjournal.com/article/S1098-3015(22)02510-4/fulltext
Title :
EE53 The Net Monetary Benefit of Introducing Sodium-Glucose Cotransporter-2 Inhibitors in Middle-Income Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02510-4&doi=10.1016/j.jval.2022.09.306
First page :
Section Title :
Open access? :
No
Section Order :
12112